Mitochondrial Dysfunction in Genetic and Non-Genetic Parkinson’s Disease
International Journal of Molecular Sciences · 07.05.2025 · 26 (9) · 4451
DOI: 10.3390/ijms26094451 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 07.05.2025. Verfasst von Martina Lucchesi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, University of Pisa, 56127 Pisa, Italy. Hauptthemen laut MEDLINE: Parkinson Disease, Mitochondria. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 257 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Resilience Plan (NRRP) - Mission 4, Component 2, Investment n. 1.4 - CUP N. B83C22003930001 (Tuscany Health Ecosystem - THE, Spoke 8), Italian Ministry of Health, Resilience Plan (NRRP).
Abstract (Originalsprache)
Mitochondrial dysfunction is a hallmark of Parkinson’s disease (PD) pathogenesis, contributing to increased oxidative stress and impaired endo-lysosomal-proteasome system efficiency underlying neuronal injury. Genetic studies have identified 19 monogenic mutations—accounting for ~10% of PD cases—that affect mitochondrial function and are associated with early- or late-onset PD. Early-onset forms typically involve genes encoding proteins essential for mitochondrial quality control, including mitophagy and structural maintenance, while late-onset mutations impair mitochondrial dynamics, bioenergetics, and trafficking. Atypical juvenile genetic syndromes also exhibit mitochondrial abnormalities. In idiopathic PD, environmental neurotoxins such as pesticides and MPTP act as mitochondrial inhibitors, disrupting complex I activity and increasing reactive oxygen species. These converging pathways underscore mitochondria as a central node in PD pathology. This review explores the overlapping and distinct mitochondrial mechanisms in genetic and non-genetic PD, emphasizing their role in neuronal vulnerability. Targeting mitochondrial dysfunction finally offers a promising therapeutic avenue to slow or modify disease progression by intervening at a key point of neurodegenerative convergence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, University of Pisa, 56127 Pisa, Italy.
- Department of Translational Research and of New Surgical and Medical Technologies, University of Pisa, 56126 Pisa, Italy.
- Department of Developmental Neuroscience, IRCCS Stella Maris Foundation, 56128 Pisa, Italy.
- Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.
- Molecular Medicine for Neurodegenerative and Neuromuscular Diseases Unit, IRCCS Stella Maris Foundation, 56128 Pisa, Italy.
ORCID-Profile: Martina Lucchesi, Letizia Biso, Bianca Buchignani, Roberta Battini, Stefano Doccini
Förderung
- Resilience Plan (NRRP) - Mission 4, Component 2, Investment n. 1.4 - CUP N. B83C22003930001 (Tuscany Health Ecosystem - THE, Spoke 8)
- Italian Ministry of Health
- Resilience Plan (NRRP)
Zitieren
APA
Lucchesi, M., Biso, L., Bonaso, M., Longoni, B., Buchignani, B., Battini, R., Santorelli, F. M., Doccini, S., & Scarselli, M. (2025). Mitochondrial Dysfunction in Genetic and Non-Genetic Parkinson’s Disease. International Journal of Molecular Sciences, 26(9), 4451. https://doi.org/10.3390/ijms26094451
Vancouver
Lucchesi M, Biso L, Bonaso M, Longoni B, Buchignani B, Battini R, et al. Mitochondrial Dysfunction in Genetic and Non-Genetic Parkinson’s Disease. International Journal of Molecular Sciences. 2025;26(9):4451. doi:10.3390/ijms26094451
BibTeX
@article{Lucchesi2025,
author = {Lucchesi, Martina and Biso, Letizia and Bonaso, Marco and Longoni, Biancamaria and Buchignani, Bianca and Battini, Roberta and Santorelli, Filippo Maria and Doccini, Stefano and Scarselli, Marco},
title = {Mitochondrial Dysfunction in Genetic and Non-Genetic Parkinson’s Disease},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {9},
pages = {4451},
doi = {10.3390/ijms26094451}
}
EUVIMED